Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹95 Cr₹155 Cr₹179 Cr₹174 Cr₹82 Cr

What is the latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES ?

The latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES is ₹95 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹95 Cr
Mar2024₹155 Cr
Mar2023₹179 Cr
Mar2022₹174 Cr
Mar2021₹82 Cr

How is Cash Flow from Operating Activities of INDOCO REMEDIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹95 Cr
-38.91
Mar2024 ₹155 Cr
-13.11
Mar2023 ₹179 Cr
2.88
Mar2022 ₹174 Cr
111.41
Mar2021 ₹82 Cr -

Compare Cash Flow from Operating Activities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,961.4 Cr -0.6% -0.9% -10.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,591.0 Cr 3.2% 12.5% 10.6% Stock Analytics
DIVIS LABORATORIES ₹183,512.0 Cr 2.9% 8.5% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,850.0 Cr 0.3% 5.7% 36.3% Stock Analytics
CIPLA ₹113,884.0 Cr 10.4% 15.9% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹111,339.0 Cr 4.8% 9% 10.8% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-0.6%

-0.9%

-10.7%

SENSEX

0.9%

-3.6%

-7.3%


You may also like the below Video Courses